Rojo Todo, Federico Gustavo federico.rojo@uam.es
Publications
- Articles 308
- Books 0
- Book chapters 1
- Conferences 21
- Working papers 0
- Technical reports 1
- Research projects 0
- Supervised theses 6
- Patent or software license 0
FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA Trial
- Rojo, F
- Taylor, CR
- Barrios, C
- Torrecillas, L
- Ruiz-Borrego, M
- Perez-Buira, S
- Bines, J
- Guerrero-Zotano, A
- Garcia-Saenz, JA
- Torres, R
- de la Haba-rodriguez, J
- Ayala, F
- Gomez, H
- Llombart, A
- de la Borbolla, MR
- Baena-Cañada, JM
- Barnadas, A
- Calvo, L
- Herranz, J
- Rincon, R
- Caballero, R
- Bermejo, B
- Ray, PS
- Martin, M
Clinical Cancer Research (p. 3715-3724) - 2/9/2025
10.1158/1078-0432.ccr-25-0338 View at source
- ISSN 15573265
Reply to: Germline and Somatic BRCA1/2 Mutations in Breast Cancer Treatment Strategies.
- Hahnen E
- Hauke J
- Gelmon K
- Marmé F
- Ernst C
- Martin M
- Untch M
- Bonnefoi H
- Knudsen E
- Im SA
- DeMichele A
- Van't Veer L
- Kim SB
- Bear H
- McCarthy N
- Rhiem K
- Turner N
- Witkiewicz A
- Rojo F
- Filipits M
- Martin LA
- Fasching PA
- Schem C
- Becker K
- García-Sáenz JA
- Kelly CM
- Reimer T
- Toi M
- Rugo HS
- Denkert C
- Gnant M
- Makris A
- Liu Y
- Valota O
- Felder B
- Weber K
- Nekljudova V
- Loibl S
Jco Precision Oncology - 1/9/2025
10.1200/po-25-00588 View at source
- ISSN 24734284
Effects of presurgical HIIT in hormone receptor-positive, HER 2-negative breast cancer cases: Two case reports from the GEICAM EFiK study
- Pérez-Bilbao, T
- López-Tarruella, S
- Alonso-Dueñas, M
- San Juan, AF
- Ferreres-García, K
- Martín, M
- Peinado, AB
- Rojo, F
Physiological Reports - 26/8/2025
10.14814/phy2.70511 View at source
- ISSN 2051817X
TIM3+breast cancer cells license immune evasion during micrometastasis outbreak
- Rozalén, C
- Sangrador, I
- Avalle, S
- Blasco-Benito, S
- Tzortzi, P
- Sanz-Flores, M
- Palomeque, JA
- Torren-Duran, P
- Dalmau, M
- Brunel, H
- Coll-Manzano, A
- Perez-Núñez, I
- Martos, T
- Servitja, S
- Pérez-Buira, S
- Chacón, JI
- Guerrero-Zotano, A
- de Dueñas, EM
- Guillén, Y
- Comerma, L
- Bornejo, B
- Bigas, A
- Casanova-Acebes, M
- Alemany, A
- Rojo, F
- Albanell, J
- Celia-Terrassa, T
Cancer Cell (p. 1549-1567.e9) - 11/8/2025
10.1016/j.ccell.2025.06.015 View at source
- ISSN 15356108
MET pathway inhibition increases chemo-immunotherapy efficacy in small cell lung cancer
- del Rey-Vergara R
- Galindo-Campos MA
- Rocha P
- Carpes M
- Martínez C
- Masfarré L
- Menéndez S
- Quimis F
- Rossell A
- Iñañez A
- Pérez-Buira S
- Rojo F
- Gimeno R
- Isla D
- Zugazagoitia J
- Martí Blanco C
- García-Campelo R
- Moreno-Vega A
- León-Mateos L
- Callejo Mellén Á
- Park KS
- Heeke S
- Heymach JV
- Taus Á
- Paz-Ares L
- Rovira A
- Arriola E
Cell Reports Medicine - 15/7/2025
10.1016/j.xcrm.2025.102194 View at source
- ISSN 26663791
FOXC1 expression predicts capecitabine efficacy in triple-negative breast cancer patients from the GEICAM_CIBOMA trial.
- Rojo F
- Taylor CR
- Barrios C
- Torrecillas L
- Ruiz-Borrego M
- Perez-Buira S
- Bines J
- Guerrero-Zotano A
- Garcia-Saenz JA
- Torres R
- de la Haba-Rodriguez J
- Ayala F
- Gomez H
- Llombart A
- Rodriguez de la Borbolla M
- Baena-Cañada JM
- Barnadas A
- Calvo L
- Herranz J
- Rincon R
- Caballero R
- Bermejo B
- Ray PS
- Martín M
Clinical cancer research : an official journal of the American Association for Cancer Research - 26/6/2025
- ISSN 15573265
- iMarina
Global Study on the Accuracy of Human Epidermal Growth Factor Receptor 2-Low Diagnosis in Breast Cancer
- Ruschoff J
- Penner A
- Ellis IO
- Hammond MEH
- Lebeau A
- Osamura RY
- Penault-Llorca F
- Rojo F
- Desai C
- Moh A
- Atkey N
- Baenfer G
- Scheel AH
- D’Arrigo C
- Schildhaus HU
- Viale G
Archives Of Pathology & Laboratory Medicine (p. 431-438) - 1/5/2025
10.5858/arpa.2024-0052-oa View at source
- ISSN 00039985
BRCA1/2 and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2-Breast Cancer Treated with Endocrine Therapy with or Without Palbociclib: A Secondary PENELOPE-B Study Analysis
- Hahnen E
- Hauke J
- Gelmon K
- Marmé F
- Ernst C
- Martin M
- Untch M
- Bonnefoi H
- Knudsen E
- Im SA
- Demichele A
- Van\'T Veer L
- Kim SB
- Bear H
- McCarthy N
- Rhiem K
- Turner N
- Witkiewicz A
- Rojo F
- Filipits M
- Martin LA
- Fasching PA
- Schem C
- Becker K
- García-Sáenz JA
- Kelly CM
- Reimer T
- Toi M
- Rugo HS
- Denkert C
- Gnant M
- Makris A
- Liu Y
- Valota O
- Felder B
- Weber K
- Nekljudova V
- Loibl S
Jco Precision Oncology - 1/4/2025
10.1200/po-24-00742 View at source
- ISSN 24734284
Dynamics of molecular heterogeneity in high-risk luminal breast cancer—From intrinsic to adaptive subtyping
- Denkert C
- Rachakonda S
- Karn T
- Weber K
- Martin M
- Marmé F
- Untch M
- Bonnefoi H
- Kim SB
- Seiler S
- Bear HD
- Witkiewicz AK
- Im SA
- DeMichele A
- Pehl A
- van\'t Veer L
- McCarthy N
- Stiewe T
- Jank P
- Gelmon KA
- García-Sáenz JA
- Westhoff CC
- Kelly CM
- Reimer T
- Felder B
- Olivé MM
- Knudsen ES
- Turner N
- Rojo F
- Schmitt WD
- Fasching PA
- Teply-Szymanski J
- Zhang Z
- Toi M
- Rugo HS
- Gnant M
- Makris A
- Holtschmidt J
- Nekljudova V
- Loibl S
Cancer Cell (p. 232-247.e4) - 10/2/2025
10.1016/j.ccell.2025.01.002 View at source
- ISSN 15356108
Adaptive Proteomic Changes in Protein Metabolism and Mitochondrial Alterations Associated with Resistance to Trastuzumab and Pertuzumab Therapy in HER2-Positive Breast Cancer
- Madoz-Gúrpide, J
- Serrano-López, J
- Sanz-alvarez, M
- Morales-Gallego, M
- Rodríguez-Pinilla, SM
- Rovira, A
- Albanell, J
- Rojo, F
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1/2/2025
10.3390/ijms26041559 View at source
- ISSN 14220067
This researcher has no books.
Molecular Pathology as a Way to Find the Right Dose for a Drug
- Rojo F
- Rovira A
- Serrano S
- Albanell J
Molecular Pathology In Drug Discovery And Development (p. 143-168) - 10/11/2008
Analytical Validation of HRD Calculation Performed with the OncoDEEP Comprehensive Genomic Panel
- Lefevre, Simon
- Ruano, Yolanda
- Rodriguez Peralto, Jose Luis
- Rojo Todo, Federico
- Carvajal Garcia, Nerea
- Abdulkader Nallib, Ihab
- Sanchez Ares, Maria
- Hernandez Losa, Javier
- Sese Faustino, Marta
- Ashour Garrido, Karim
- Lienard, Maxime
- Hong, Jessie
- Elias, Marc
- Rodrigo Martinez, Ana Belen
- Felipo Benavent, Amelia
Journal Of Molecular Diagnostics (p. S44-S44) - 1/6/2024
- ISSN 15251578
- iMarina
Use of liquid biomarker thymidine kinase activity (TKa) to predict outcome and progression in patients with metastatic breast cancer (MBC) in the GEICAM/2014-12 FLIPPER trial
- Albanell, Joan
- Williams, Amy
- Teresa Martinez, Maria
- Ritzen, Hanna
- Paris, Lorena
- O'Connor, Miriam
- De la Cruz Merino, Luis
- Santaballa, Ana
- Martinez-Janez, Noelia
- Anton, Fernando Moreno
- Fernandez, Isaura
- Company, Jesus Alarcon
- Guerra, Juan Antonio
- Ruiz-Borrego, Manuel
- Morris, Patrick G
- Portela, Marta
- Herranz, Jesus
- Caballero, Rosalia
- Bergqvist, Mattias
- Rojo Todo, Federico Gustavo
Journal Of Clinical Oncology - 1/6/2024
- ISSN 0732183X
- iMarina
Evaluating Ki67 and Oncotype DX Breast Recurrence Score during neoadjuvant treatment with letrozole/abemaciclib or chemotherapy in patients with highly proliferative HR+/HER2-breast cancer participating in the GEICAM CARABELA trial
- Guerrero, Angel
- Martin, Miguel
- Eva Perez, Maria
- Ruiz-Borrego, Manuel
- Martinez-Janez, Noelia
- Ignacio Chacon, Jose
- Gil Gil, Miguel J
- Andres, Raquel
- Sanchez-Rovira, Pedro
- Del Barco, Sonia
- Bermejo, Begona
- Fernandez, Isaura
- Garcia, Elisa
- Hernando, Blanca
- De La Haba, Juan
- Herranz, Jesus
- Portela, Marta
- Caballero, Rosalia
- Rojo Todo, Federico Gustavo
- Alba Conejo, Emilio
Journal Of Clinical Oncology - 1/6/2024
- ISSN 0732183X
- iMarina
Relationship of adaptive subtyping and tumour heterogeneity of treatment response to neoadjuvant therapy in hormone receptor-positive HER2-negative early breast cancer: PENELOPE-B
- Denkert, Carsten
- Rachakonda, Krishna
- Filipits, Martin
- Weber, Karsten
- Marme, Frederik
- Untch, Michael
- Witkiewicz, Agnieszka K
- Im, Seock-Ah
- DeMichele, Angela
- Pehl, Anika
- Van' t Veer, Laura
- Jank, Paul
- Schem, Christian
- Fasching, Peter A
- Reimer, Toralf
- Knudsen, Erik S
- Liu, Yuan
- Todo, Federico Gustavo Rojo
- Turner, Nicholas C
- Loibl, Sibylle
Journal Of Clinical Oncology - 1/6/2024
- ISSN 0732183X
- iMarina
Comprehensive clinical characteristics and ctDNA mutational profile analysis of endocrine resistance/sensitivity to adjuvant ET therapy in luminal breast cancer from the GEICAM/2014-03_RegistEM registry
- Guerrero, Angel
- Alvarez, Isabel
- Antolin Novoa, Silvia
- Cruz Jurado, Josefina
- Rodriguez Sanchez, Cesar Augusto
- Martinez, Purificacion
- Falo, Catalina
- Hernandez-Sosa, Maria
- Margeli, Mireia
- Gonzalez Maeso, Iria
- Rodriguez-Lescure, Alvaro
- Marin Alcala, Maria
- Anton, Antonio
- Varela Ferreiro, Silvia
- Herranz, Jesus
- Caballero, Rosalia
- Fernandez Garcia, Daniel
- Tibau, Ariadna
- Cobo, Sara Lopez-Tarruella
- Rojo Todo, Federico Gustavo
Journal Of Clinical Oncology - 1/6/2024
- ISSN 0732183X
- iMarina
Non-basal subtype defined by FOXC1 expression as an independent predictor of capecitabine efficacy in the triple negative breast cancer GEICAM/2003-11_CIBOMA/2004-01 trial
- Todo, Federico Gustavo Rojo
- Taylor, Clive R
- Barrios, Carlos H, Sr
- Torrecillas, Laura
- Ruiz-Borrego, Manuel
- Bines, Jose
- Segalla, Jose G M
- Guerrero, Angel
- Garcia-Saenz, Jose A
- Torres, Roberto
- De La Haba, Juan
- Ayala, Francisco
- Gomez, Henry Leonidas
- Llombart, Antonio
- Herranz, Jesus
- Rincon, Raul
- Caballero, Rosalia
- Bermejo, Begona
- Ray, Partha S
- Martin, Miguel
Journal Of Clinical Oncology - 1/6/2024
- ISSN 0732183X
- iMarina
Cost-benefit analysis of ALK diagnosis in patients with non-small cell lung cancer in Spain
- Ortega Granados, A L
- Rojo Todo, F
- Alvarez Alvarez, R
- Majem Tarruella, M
- Ruiz de Alda Iparraguirre, L
- Garcia Verdes-Montenegro, J F
- Gordo Flores, R
- Gonzalez-Dominguez, A
- Ivanova Markova, Y
- Sanchez San Cristobal, R
Annals Of Oncology (p. S960-S960) - 21/9/2021
10.1016/j.annonc.2021.08.1809 View at source
- ISSN 09237534
A prognostic signature based on two-miRNA and pathological data in early-stage HER2+breast cancer patients
- Adam Artigues, A
- Beltran, M A
- Carbonell-Asins, J A
- Zuniga, S
- Moragon, S
- Martinez, M T M
- Hernando Melia, C
- Burgues, O
- Rojo Todo, F
- Albanell Mestres, J
- Lluch-Hernandez, A
- Bermejo, B
- Eroles, P
- Cejalvo, J M
Annals Of Oncology (p. S442-S442) - 21/9/2021
10.1016/j.annonc.2021.08.476 View at source
- ISSN 09237534
MicroRNAs-449 regulate doxorubicin response through ACSL4 modulation in TNBC
- Torres Ruiz, S
- Garrido Cano, I
- Cervera Vidal, R
- Hernando Melia, C
- Martinez, M T M
- Zazo, S
- Burgues, O
- Rojo Todo, F
- Bermejo, B
- Lluch-Hernandez, A
- Cejalvo Andujar, J M
- Eroles, P
- Tormo Martin, E
Annals Of Oncology (p. S494-S495) - 21/9/2021
10.1016/j.annonc.2021.08.582 View at source
- ISSN 09237534
A phase II proof-of-concept study of palbociclib (P) rechallenge in patients (pts) with hormone receptor (HR)[+]/HER2[-] metastatic breast cancer (MBC) and clinical benefit to prior P-based treatment (BIOPER)
- Llombart-Cussac, Antonio
- Cortes, Javier
- Bellosillo Paricio, Beatriz
- Gil Gil, Miguel
- Curigliano, Giuseppe
- Manuel Perez-Garcia, Jose
- Comerma Blesa, Laura
- Ruiz Borrego, Manuel
- Espinosa, Enrique
- Calvo, Lourdes
- Bermejo, Begona
- Bellet, Meritxell
- Rojo Todo, Federico
- de la Haba, Juan
- Quiroga, Vanesa
- Minisini, Alessandro
- Santaballa, Ana
- Sampayo, Miguel
- Malfettone, Andrea
- Albanell, Joan
Cancer Research - 1/2/2021
- ISSN 00085472
- iMarina
This researcher has no working papers.
Palbociclib Rechallenge for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial
- Albanell J, Pérez-García JM, Gil-Gil M, Curigliano G, Ruíz-Borrego M, Comerma L, Gibert J, Bellet M, Bermejo B, Calvo L, de la Haba J, Espinosa E, Minisini AM, Quiroga V, Santaballa Bertran A, Mina L, Bellosillo B, Rojo F, Menéndez S, Sampayo-Cordero M, Popa C, Malfettone A, Cortés J, Llombart-Cussac A
Clinical Cancer Research (p. 67-80) - 1/1/2022
10.1158/1078-0432.ccr-22-1281 View at source
- ISSN 15573265
This researcher has no research projects.
Identification of molecular mechanisms of acquired resistance to trastuzumab in HER2+ breast cancer
- Rojo Todo, Federico (Director)
- Moreno Bueno, Gema (Tutor) Doctorando: González Alonso, Paula
24/4/2019
- iMarina
ntegración en la rutina diagnóstica de la clasificación molecular de los tumores gliales
- Fortes Alen, Jose Roman (Director)
- Rojo Todo, Federico (Director)
- José Fortes Alén (Director)
- Federico Rojo (Director) Doctorando: Daoud, Lina
9/3/2017
- iMarina
Mecanismos de resistencia primaria y adquirida a trastuzumab en cáncer de mama HER2 positivo
- Manzarbeitia Arambarri, Félix (Director)
- Rojo Todo, Federico (Director)
- Manzarbeitia Arambarri, Felix Daniel (Director) Doctorando: Zazo Hernández, Sandra
1/1/2017
- iMarina
Fenotipos intrínsecos y resultados clínico-patológicos del tratamiento neoadyuvante en pacientes con cáncer de mama
- Maria Dolors Sabadell Mercadal
1/1/2017
- iMarina
Activación de las vías HGF/MET e HIPPO como predictores de resistencia al tratamiento con anticuerpos anti-EGFR en pacientes con carcinoma escamoso de cabeza y cuello recurrente o metastásico
- Luz María Martín Fragueiro
1/1/2017
- iMarina
This researcher has no patents or software licenses.
Researcher profiles
-
ORCID
-
Scopus Author ID
-
Dialnet id